Acta Pharmaceutica Sinica B : Impact Factor & More
eISSN: 2211-3843pISSN: 2211-3835
Open AccessShare this on:
Key Metrics
CiteScore 
15.9
Eigenfactor
< 0.001
Impact Factor
10 - 15
Scite Index
0.95 5-Year SI
SJR
Q1Pharmacology, Toxicology and Pharmaceutics (all)
SNIP
2.59
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Acta Pharmaceutica Sinica B
Acta Pharmaceutica Sinica B Journal Specifications
| Overview | |
| Publisher | INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES |
| Language | English |
| Frequency | Bi-monthly |
| Publication Time | 19 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Insititute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association |
| Frequency | Bi-monthly |
| Publication Start Year | 2011 |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Acta Pharmaceutica Sinica B ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Acta Pharmaceutica Sinica B
From target specificity to metabolic efficiency: Design and optimization of etomidate analogues for potential improvement in postoperative outcomes
- 1 Jan 2026
- Acta Pharmaceutica Sinica B
An integrated resource for ischemic heart disease defines hallmarks and heterogeneity across time and space.
- 1 Jan 2026
- Acta pharmaceutica Sinica. B
Aberrant astroglial Kir4.1 activation in the anterior cingulate cortex disrupts neuronal excitability and social behavior
- 1 Jan 2026
- Acta Pharmaceutica Sinica B
Multi-omics-based identification of METTL11B as a novel biomarker in esophageal squamous cell carcinoma
- 1 Jan 2026
- Acta Pharmaceutica Sinica B
Artificial intelligence in precision mRNA therapeutics: Towards genomic language models and multi-agent virtual humans
- 1 Jan 2026
- Acta Pharmaceutica Sinica B
Advances in immune cell-based therapeutic agents for the treatment of inflammation-related diseases
- 1 Jan 2026
- Acta Pharmaceutica Sinica B
From target specificity to metabolic efficiency: Design and optimization of etomidate analogues for potential improvement in postoperative outcomes
- 1 Jan 2026
- Acta Pharmaceutica Sinica B
An integrated resource for ischemic heart disease defines hallmarks and heterogeneity across time and space.
- 1 Jan 2026
- Acta pharmaceutica Sinica. B
Aberrant astroglial Kir4.1 activation in the anterior cingulate cortex disrupts neuronal excitability and social behavior
- 1 Jan 2026
- Acta Pharmaceutica Sinica B
Multi-omics-based identification of METTL11B as a novel biomarker in esophageal squamous cell carcinoma
- 1 Jan 2026
- Acta Pharmaceutica Sinica B
Artificial intelligence in precision mRNA therapeutics: Towards genomic language models and multi-agent virtual humans
- 1 Jan 2026
- Acta Pharmaceutica Sinica B
Advances in immune cell-based therapeutic agents for the treatment of inflammation-related diseases
- 1 Jan 2026
- Acta Pharmaceutica Sinica B
FAQs on Acta Pharmaceutica Sinica B
How long has Acta Pharmaceutica Sinica B been actively publishing? 
What is the publishing frequency of Acta Pharmaceutica Sinica B?
How many articles did Acta Pharmaceutica Sinica B publish last year?
What is the eISSN & pISSN for Acta Pharmaceutica Sinica B?
What is Citescore for Acta Pharmaceutica Sinica B?
What is SNIP score for Acta Pharmaceutica Sinica B?
What is the SJR for Acta Pharmaceutica Sinica B?
Who is the publisher of Acta Pharmaceutica Sinica B?
